Li Guandang, General Manager, stated that the signing of the agreement has far-reaching significance and impact on both sides. He hopes that in the future, there will be deeper cooperation in the areas of technology transfer, enterprise synergy and empowerment, and health management services, further gathering resources from various sides to promote the development of the medical industry ecosystem.

   Secretary Zeng Bin pointed out that both sides should leverage their respective strengths and advantages to achieve strong cooperation and deep integration for mutual benefit. First, they should focus on cooperation projects, promote mutual promotion and win-win results, and ensure that scientific and technological research and innovation projects are implemented effectively. Second, they should expand the scope of cooperation, promote information sharing, and support more biopharmaceutical enterprises to provide empowerment services. Third, they should deepen cooperation mechanisms, promote mutual progress, enrich and expand cooperation in various aspects of the pharmaceutical industry, capital market, and other areas, and explore new ways and provide new ideas for accelerating the development of the pharmaceutical industry.

     Both sides signed a strategic cooperation framework agreement.
   Later on, both parties will carry out close cooperation in seven major areas of horizontal scientific research topics on cutting-edge technological innovation, vertical scientific research topics on cutting-edge technological innovation, clinical and IIT research on cutting-edge technological innovation in healthcare, pre-clinical research cooperation, academic exchange, healthcare projects, and corporate financial advisory consulting services, leveraging their respective strengths to achieve mutual development.